1. Home
  2. EDSA vs BANL Comparison

EDSA vs BANL Comparison

Compare EDSA & BANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • BANL
  • Stock Information
  • Founded
  • EDSA 2015
  • BANL 2015
  • Country
  • EDSA Canada
  • BANL Malaysia
  • Employees
  • EDSA N/A
  • BANL N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • BANL Oil Refining/Marketing
  • Sector
  • EDSA Health Care
  • BANL Energy
  • Exchange
  • EDSA Nasdaq
  • BANL Nasdaq
  • Market Cap
  • EDSA 18.6M
  • BANL 19.5M
  • IPO Year
  • EDSA N/A
  • BANL 2023
  • Fundamental
  • Price
  • EDSA $2.66
  • BANL $0.54
  • Analyst Decision
  • EDSA Strong Buy
  • BANL
  • Analyst Count
  • EDSA 2
  • BANL 0
  • Target Price
  • EDSA $13.00
  • BANL N/A
  • AVG Volume (30 Days)
  • EDSA 140.8K
  • BANL 366.7K
  • Earning Date
  • EDSA 12-12-2025
  • BANL 09-04-2025
  • Dividend Yield
  • EDSA N/A
  • BANL N/A
  • EPS Growth
  • EDSA N/A
  • BANL N/A
  • EPS
  • EDSA N/A
  • BANL N/A
  • Revenue
  • EDSA N/A
  • BANL $580,456,800.00
  • Revenue This Year
  • EDSA N/A
  • BANL N/A
  • Revenue Next Year
  • EDSA N/A
  • BANL N/A
  • P/E Ratio
  • EDSA N/A
  • BANL N/A
  • Revenue Growth
  • EDSA N/A
  • BANL 11.38
  • 52 Week Low
  • EDSA $1.55
  • BANL $0.51
  • 52 Week High
  • EDSA $4.49
  • BANL $1.30
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 54.92
  • BANL 23.53
  • Support Level
  • EDSA $2.42
  • BANL $0.51
  • Resistance Level
  • EDSA $2.95
  • BANL $0.78
  • Average True Range (ATR)
  • EDSA 0.21
  • BANL 0.05
  • MACD
  • EDSA 0.01
  • BANL -0.02
  • Stochastic Oscillator
  • EDSA 49.86
  • BANL 18.03

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

Share on Social Networks: